All About Alzheimer's Caring Conversations
For the first time, drugs targeting amyloid plaques have moved beyond trials and into real world use. Treatments like Kisunla and Leqembi, approved in 2023 and 2024, have helped validate the long debated amyloid theory.
13 episodes
Comments
0Be the first to comment
Sign up now and become a member of the All About Alzheimer's Caring Conversations community!